Latest news with #Liechtenstein
BBC News
2 days ago
- Sport
- BBC News
'Fantastic' Miller's future 'not at top of my mind'
Jens Berthel Askou says "fantastic" Lennon Miller's future has "not been top of my mind" - but the Motherwell boss admits "there probably is" interest in the 18-year-old midfielder has been given extended time off after impressing in his first start for Scotland in Liechtenstein last continues to surround the future of Fir Park youth product, who has a year left to run on his Askou is unsure whether this summer is the time when Miller will "take the next step" in his career."There probably is [interest in him], but it's not been top of my mind," the new Well manager said. "I'll probably need to get that update myself. I know he's a fantastic player, he's just gone into the national team, he's a big profile for Scottish football."For sure he's going to face a fantastic international career, then we'll see over time if it's going to be this summer that he will take the next step. "I haven't met him yet because he's got a few extra days off, so I think it would be fair for me to meet him first and have some good discussions with him before I answer any specific questions about his future."
BBC News
2 days ago
- Sport
- BBC News
Swifts to play Vaduz and Reds could face Shamrock Rovers
Irish Cup winners Dungannon Swifts will face Liechtenstein side FC Vaduz in their first European fixture in 18 McAree's side enter the Uefa Conference League at the second stage of qualifying, the draw for which the draw took place on the winners of the first qualifying round tie between Irish Premiership European play-off winners Cliftonville and St Joseph's of Gibraltar will face League of Ireland Premier Division side Shamrock Rovers in the second qualifying will take on FC Sheriff Tiraspol of Moldova or FC Prishtina of Kosovo should they defeat Latvian outfit FRK Auda in round Premiership champions Linfield could face familiar opposition in the form of Qarabag if they overcome Shelbourne in the first round of Champions League first leg of that tie will be played on 22 or 23 July, with the Blues or Shels at home, followed by the second leg on 29 or 30 Healy's side lost on away goals to the Azerbaijan side in Europa League qualifying in 2019 despite a famous Shayne Lavery-inspired win at Windsor loser of the Linfield-Shelbourne tie will drop into the Conference League second round and will play the defeated side between FK Zalgiris of Lithuania and Hamrun Spartans of draw Shelbourne in Champions League qualifyingThe ties for the second round of Conference League qualifying are scheduled for Thursday, 24 and Thursday, 31 qualified for Europe by beating Cliftonville on penalties in a dramatic Irish Cup final in have twice played in Europe before, when they lost in the 2006 Intertoto Cup to Keflavik IF in the first round and in qualifying for the 2007-08 Uefa Cup, when they were defeated by Lithuanian side FK Irish Premiership clubs can progress past the second round of qualifying then they are potentially four matches away from replicating Larne's historic run to the League stage of the Conference League last season.
Associated Press
3 days ago
- Business
- Associated Press
Fineqia Appoints Psalion Group as Investment Advisor to Expand Crypto ETP Business
LONDON, UK / ACCESS Newswire / June 18, 2025 / Fineqia International Inc. ('Fineqia') (CSE:FNQ)(OTC:FNQQF)(Frankfurt:FNQA), a digital asset and investment business, announces the appointment of Psalion Operations Limited, a digital asset management firm, as an investment advisor to its Liechtenstein-based subsidiary, Fineqia AG. The appointment reinforces Fineqia's commitment to developing structured, yield-oriented crypto Exchange-Traded Products (ETPs) for investors across Europe. Psalion Operations Limited is a unit of the Psalion Group, a specialist blockchain investment firm developing and managing institutional-grade activities across the digital asset spectrum. Its capabilities span yield generation, asset structuring, and risk-managed exposure to decentralised finance protocols, as well as the operating of venture capital funds. With a focus on innovation and compliance, Psalion combines deep technical insight with disciplined investment processes to deliver robust, blockchain-native solutions for sophisticated investors. 'Psalion's proven ability to engineer sophisticated, yield-bearing crypto activities makes them an ideal partner for our next phase of growth,' said Bundeep Singh Rangar, chief executive officer of Fineqia. 'Their appointment strengthens our mission to provide compliant, forward-looking digital asset products that speak to the needs of today's investors.' 'We are truly excited to work with Fineqia on various ETPs, in particular a potential Bitcoin ETP. In a truly complementary partnership, Fineqia brings its expertise in institutional-grade investment products, and Psalion brings its expertise in creating yield products,' added Tim Enneking, managing partner of the Psalion Group. The partnership is designed to accelerate the evolution of Fineqia's ETP offering, delivering products that bridge traditional financial structures with blockchain-driven innovation. By bringing Psalion's strategic insight and track record into the fold, Fineqia continues to bring regulated digital asset investment products in Europe. Fineqia launched its inaugural crypto Exchange-Traded Note (ETN), the Fineqia FTSE Cardano Enhanced Yield ETN (Ticker: YADA; ISIN: LI1408648106), earlier this year. The partnership with Psalion marks a significant step in scaling its product roadmap, with a focus on high-performance ETPs that combine digital asset exposure with regulated DeFi-based yield activities. The partnership agreement between The Psalion Group and Fineqia AG was signed on 16 April 2025. The terms of this agreement are confidential. For more information about Fineqia and its products, please visit About Fineqia International Inc. Publicly listed in Canada (CSE: FNQ) with quoted symbols on Nasdaq (OTC: FNQQF) and the Frankfurt Stock Exchange (Frankfurt: FNQA), Fineqia provides investors with institutional grade exposure to opportunities from blockchain based Decentralized Finance (DeFi). Its European subsidiary is an issuer of crypto asset backed Exchange Traded Products (ETPs) such as the Fineqia FTSE Cardano Enhanced Yield ETN (Ticker: YADA; ISIN: LI1408648106). Fineqia has investments in businesses tokenizing Real-World Assets (RWAs), dApps, DeFi and blockchain protocols. More info at and @ London Stock Exchange Group (LSEG) Information Webinars: About Fineqia AG Fineqia AG is a wholly owned subsidiary of Fineqia International, set up to pursue business on the European continent. Fineqia AG, based in Liechtenstein, received approval of its base prospectus by the country's Financial Market Authority (FMA) to offer Exchange Traded Products (ETPs) collateralized by digital assets. Its base prospectus complies with the European Union's (EU) passport directive and enables its ETPs to be distributed across the EU's single market. About the Psalion Group The Psalion Group is a global group of companies operating in two primary business lines: generating yield on digital and traditional assets and currencies and operating venture capital funds in the blockchain and digital asset space. The Group was founded in 2020. It has offices in Paris, Singapore and San Diego. FOR FURTHER INFORMATION, PLEASE CONTACT: Warren Sergeant, Chief Financial Officer E. [email protected] T. +44 78187 11024 Aayushi Jain, Marketing Manager E. [email protected] T. +44 78778 60812 FORWARD-LOOKING STATEMENTS Some statements in this release may contain forward-looking information (as defined under applicable Canadian securities laws) ('forward-looking statements'). All statements, other than of historical fact, that address activities, events or developments that Fineqia (the 'Company') believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words 'may', 'will', 'should', 'continue', 'expect', 'anticipate', 'estimate', 'believe', 'intend', 'plan' or 'project' or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company's ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the failure to obtain sufficient financing, and other risks disclosed in the Company's public disclosure record on file with the relevant securities regulatory authorities. Any forward-looking statement speaks only as of the date on which it is made except as may be required by applicable securities laws. The Company disclaims any intent or obligation to update any forward-looking statement except to the extent required by applicable securities laws. DISCLAIMER: Crypto assets are unregulated investment products prone to sudden and substantial value fluctuations, presenting a high risk of total loss of the invested capital. As the underlying components of the Fineqia FTSE Cardano Enhanced Yield ETN (Ticker: YADA; ISIN: LI1408648106) are unregulated, investors are unlikely to have access to regulatory protections or investor compensation schemes. If you are unsure whether these assets are suitable for your individual circumstances, it is highly recommended to obtain independent financial and legal advice. SOURCE: Fineqia press release
Yahoo
4 days ago
- Health
- Yahoo
Implantica announces successful UK RefluxStop™ Users Meeting addressing growing demand after the final and positive UK NICE recommendations on use of RefluxStop in NHS public hospitals
VADUZ, Liechtenstein, June 17, 2025 /PRNewswire/ -- Implantica AG (publ.), a MedTech company at the forefront of treatment for acid reflux with its unique device RefluxStop™, a treatment field with 1 billion sufferers, announces the successful first UK National Users Meeting bringing together 21 top anti-reflux experts in UK last week. Surgeons exchanged their real-world experiences and delved into the positive National Institute for Health and Care Excellence (NICE) recommendations on using RefluxStop in NHS hospitals, opening a vast opportunity for RefluxStop procedures in patients with poor motility, representing up to 40-50%1 of the acid reflux (GERD/GORD) sufferers. Mr. Ahmed Ahmed, a renowned anti-reflux surgeon at the Imperial College Healthcare NHS Trust, says, "As more and more patients ask for RefluxStop, I'm very pleased to play a part in this unique opportunity to collaborate with my colleagues to offer the latest and greatest treatment options to our GERD patients, such as RefluxStop. I'm already seeing a rapidly growing demand for RefluxStop, in line with excellent outcomes achieved in my current RefluxStop patients. The recent positive NICE recommendations now allow the use of RefluxStop in NHS hospitals, which is a testament to the UK healthcare system's prioritization and focus on making the best treatments available to UK patients as soon as possible. On behalf of the GERD community, I would like to thank NICE and all involved stakeholders for their dedication to helping GERD patients who truly need effective treatment for this debilitating disease." Founder and CEO of Implantica, Dr. Peter Forsell, adds, "We sincerely thank and appreciate the world-leading healthcare policy advisory body, UK NICE, for their extensive and thorough review and announcement of the final positive recommendations for the RefluxStop™ procedure. Given how rampant GERD is in the UK, with up to 20% of the adult population struggling with the persistent discomfort and pain from the disease, the NICE recommendations for RefluxStop procedure couldn't be more appreciated among UK specialists, addressing the huge unmet need and treatment gap, especially for the GERD patients who have poor dysmotility.¹ Dr Forsell continues, "I'm truly impressed by the great enthusiasm for RefluxStop™ from the esteemed UK surgeons and other experts. Following the highly successful UK RefluxStop™ users meeting where several UK surgeons presented their excellent outcomes and patient satisfaction results, and now with the very supportive NICE recommendations, it's clear to me that RefluxStop™ will transform the reflux treatment landscape in the UK, and ultimately worldwide, in the coming future." 1Shih-Chi Ho et al., Ineffective esophageal motility is a primary motility disorder in gastroesophageal reflux disease. Digestive Diseases and Sciences, 2002. 47(3): 652-6 For further information, please contact: Nicole Pehrsson, Chief Corporate Affairs OfficerTelephone (CH): +41 (0)79 335 09 Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm. The company's Certified Adviser is FNCA Sweden AB, info@ The information was sent for publication, through the agency of the contact person set out above, on 17. June 2025, at 08:00 a.m. (CET). About Implantica Implantica is a MedTech group dedicated to bringing advanced technology into the body. Implantica's lead product, RefluxStop™, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energizing platform designed to power remote-controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit for further information. About RefluxStop™ RefluxStop™ is a new innovative treatment that has the potential to spur a paradigm shift in anti-reflux surgery. It's unique mechanism of action differentiates it from standard of care and current surgical solutions. Longer established surgical options for GERD involve encircling the food passageway to support the lower esophageal sphincter's closing mechanism and are commonly associated with side effects such as swallowing difficulties, pain when swallowing and inability to belch and/or vomit. In contrast, the RefluxStop™ device treats the cause of acid reflux without encircling and putting pressure on the food passageway. It restores and maintains the lower esophageal sphincter in its original, natural position. The RefluxStop™ mechanism of action is focused on reconstructing all three components of the anti-reflux barrier, that if compromised could possibly result in acid reflux. It restores and supports the natural anatomical physiology of the body allowing the body to itself solve the problem with acid reflux. Newsroom Community Media Contact: Implantica AGJuanita Eberhart, VP Marketing & AdvocacyM: +1 This information was brought to you by Cision The following files are available for download: Implantica announces successful UK RefluxStopâ'¢ Users Meeting addressing growing demand after the final and positive UK NICE recommendations on use of RefluxStop in NHS public hospitals logo transparent 1 8 ReluxStop Product View original content: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Daily Mail
6 days ago
- Sport
- Daily Mail
In Case You Missed It: Scottish sport under the microscope like never before as alarm bells sound for the future
The current state of Scottish sport has been a hot topic in Mail Sport this week, with rugby, tennis and football all coming under the microscope. The week began, of course, with the nation feeling rather glum in the wake of that Hampden humbling against Iceland, with the prospect of a meaningless — yet dangerous — friendly in Liechtenstein failing to get anyone excited. Such was the sense of hopelessness that our very own Calum Crowe sounded the death knell for our hopes of reaching the 2026 World Cup before a ball has even been kicked in our qualification campaign. The subsequent 4-0 cruise in Vaduz at least managed to turn down the heat on manager Steve Clarke, with Che Adams' hat-trick a welcome sight and hopefully a sign of better things to come. The path to the Americas begins in September with daunting away trips to Denmark and Belarus — albeit the latter fixture will most likely take place in Hungary — and SFA supremo Ian Maxwell did confirm that it is unlikely in the extreme that anyone other than Clarke will be the man at the helm. While football fills us with frustration, rugby is facing something more akin to rancour following Mail Sport's exclusive this week about the devastating cuts Scottish Rugby are imposing on the developmental game. Murrayfield chiefs have been accused of showing 'disrespect' and a 'lack of care' towards young players after announcing major changes to their academy system, with some age-grade teams having seen their number of official academy players cut in half. All this comes at a time when SRU performance director David Nucifora is still based in Australia and only visits Scotland during certain periods of the year. While so many people are affected by the drastic upheaval, Nucifora is essentially, as Calum Crowe put it so well, phoning it in from Bondi Beach. To compound a week of worry for the Scottish sporting landscape, Mail Sport's exclusive with Judy Murray was particularly ominous. On the back of the Scottish government's failure to build on the legacy of her superstar sons, Andy and Jamie, Judy accused Holyrood of continuing to fail sport in this country and revealed her fears that it is becoming a two-tier system of the 'haves' and 'have nots' in schools. Murray spent 11 years working on the failed Park of Keir project which she hoped would allow the nation to build on the Grand Slam and Olympic successes her sons achieved. Now she fears there will be no Scots in the Wimbledon juniors this year, a state of affairs she finds unacceptable. Scottish numbers dwindled on the Lions tour, too, with Zander Fagerson's withdrawal from the squad which will travel to Australia this summer officially confirmed. On the plus side, Scotland coach Gregor Townsend selected a strong squad for his side's own tour Down Under and he fully expects that some of his men will be drafted in by Lions coach Andy Farrell as injuries start to bite. On a more positive note, our intrepid groundhopper Hugh MacDonald entertained us in the absence of live football by taking us on a journey back to the times of the coal mines, exploring the inextricable links between the pit and the pitch. The legendary managerial trio of Stein, Shankly and Busby all had mining links, but it was the stories of the less heralded names, the men who would emerge from the darkness to compete for their clubs — and sometimes at a high level — that stood out from our look-back to a time that must seem so alien to many among the younger generation. Finally, if it's a more irreverent offering that you are hankering for, John McGarry's A-Z of the Scottish football season just gone is a must-read. As, of course, are our Rangers and Celtic Confidentials, available every week on Mail+.
